The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Iqvia Government Solutions Inc. to provide hospital drug utilization data and regulatory drug utilization services. The base period of performance is from March 2020 through March 2025 with a potential value of $9 million. Under the first delivery order valued at $3.667 million, Iqvia will deliver hospital drug data from Silver Spring, Maryland through April 2025.
The original solicitation sought continued direct access to commercially available hospital drug utilization data and regulatory drug utilization services to support the FDA's statutory mandate of ensuring drug safety. Specifically, the FDA's Office of Surveillance and Epidemiology requires these data resources to understand drug risks, promote safe drug use, evaluate regulatory impact studies, and accelerate regulatory decision making. Access to nationwide estimates of adult and pediatric hospital drug exposure provides context for adverse event reports and informs risk modeling, calculation of patient-based reporting rates, and examination of product labeling's usefulness to clinicians. No subcontractors or socioeconomic set asides were specified for this single award contract.
Generated 1/5/24, 1:27 AM